SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001685071-19-000014
Filing Date
2019-05-07
Accepted
2019-05-07 07:12:34
Documents
3
Period of Report
2019-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dovaq120198-kearningsrelea.htm 8-K 30708
2 EXHIBIT 99.1 dovaq12019earningsrelease.htm EX-99.1 92769
3 GRAPHIC dovaupdatedlogo.gif GRAPHIC 8934
  Complete submission text file 0001685071-19-000014.txt   137116
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 19801196
SIC: 2834 Pharmaceutical Preparations